Rashidul Alam Mahumud

Catastrophic out-of-pocket healthcare expenditures among cancer patients receiving systemic therapy and/or radiation therapy in Bangladesh

Md. Shahjalal, Khorshed Alam, Padam Kanta Dahal, Yifu Chen et autres

BACKGROUND: Cancer imposes a growing health and economic burden in low-resource settings. In Bangladesh, gaps in universal health coverage, inadequate financial protection and substantial reliance on out-of-pocket payments expose cancer-affected households to catastrophic health expenditure (CHE). This study quantified CHE across alternative …

bd, au, ae (code pays fourni par la source)

Cost-effectiveness and budget impact analysis of pembrolizumab as an adjuvant treatment of resected stage III melanoma from an Australian healthcare system perspective

Rashidul Alam Mahumud

IMPORTANCE: Stage III melanoma carries a substantial risk of recurrence despite complete surgical resection. Pembrolizumab improves recurrence-free survival, but its cost-effectiveness and potential budget impact in Australia remain important considerations. This study aims to evaluate the cost-effectiveness and potential budget impact of …

au (code pays fourni par la source)

The emerging burden of triple-negative breast cancer in Australia: Universal care does not guarantee equitable access

Nasrin Akter, Chi Kin Law, Rashidul Alam Mahumud

Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype associated with early onset, limited targeted treatment options, and disproportionately high mortality. Although Australia operates a universal health-care system, inequities in TNBC outcomes persist. We synthesise contemporary clinical, epidemiological, and policy evidence …

bd, au (code pays fourni par la source)

The Economic Burden of Gestational Diabetes and Body Mass Index Changes Between Pregnancies: A Retrospective Cohort Study

Rashidul Alam Mahumud, Glynis Pauline Ross, Adam Mackie, Rachael L. Morton et autres

ABSTRACT Objective To determine associations between gestational diabetes mellitus (GDM) and body mass index (BMI) change between consecutive pregnancies, and hospital length of stay (LOS) and hospital costs. Design Retrospective cohort study. Setting Two maternity hospitals, New South Wales, Australia. Population Women …

au (code pays fourni par la source)

Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023

Kayleigh Bhangdia, Miranda L May, Jonathan M Kocarnik, Natalie Pritchett et autres

Cancer Burden in Bangladesh: Insights From National Institute of Cancer Research & Hospital, 2014-2020

Md. Shahjalal, Padam Kanta Dahal, Md. Arifur Rahman, Sarah Tahera Mahmud et autres

PURPOSE Bangladesh, a lower-middle–income country in South Asia, faces a rapidly rising cancer burden. In the absence of a population-based cancer registry (PBCR), monitoring national patterns remains challenging and constrains evidence-informed policymaking. We analyzed temporal trends in cancer distribution at the country's …

bd, au, gb, pk, us, sg (code pays fourni par la source)

Economic value, affordability, and scale-up of adjuvant immunotherapies in lung cancer treatment: From cost-effectiveness decision to budget impact analysis

Rashidul Alam Mahumud, Yifu Chen, Padam Kanta Dahal, Nasrin Akter et autres

BACKGROUND: Adjuvant immunotherapies have transformed lung cancer management by improving survival and patient-reported quality of life. However, their high acquisition costs and uncertainty around real-world economic value raise concerns regarding health system affordability and long-term sustainability. This study assessed the cost-effectiveness of …

au, bd (code pays fourni par la source)

Frailty and disability among older adults residing in Rohingya refugee camp in Bangladesh

Afsana Anwar, Mahmood Parvez, Farhan Azim, Uday Narayan Yadav et autres

BACKGROUND: Frailty and disability often emerge with ageing and affect quality of life. Older adults residing in Rohingya refugee camp in Bangladesh are particularly susceptible to frailty and disability due to adverse physical and social environment along with limited health and social …

au, bd, us (code pays fourni par la source)

Cost-Effectiveness of Adjuvant Immunotherapy in Cancer Treatments

Rashidul Alam Mahumud, Yifu Chen, Md Shahjalal, Padam Kanta Dahal et autres

Importance: Adjuvant immunotherapy is increasingly integrated into cancer care to reduce recurrence and improve survival. However, its high cost raises critical concerns regarding affordability and economic value across diverse health system contexts. Objective: To synthesize published economic evaluations of adjuvant immunotherapy and …

au, bd (code pays fourni par la source)

Ensuring equitable access to cancer medicine and care in Australia: A human-rights lens, including people experiencing homelessness

Rashidul Alam Mahumud

Australia has strong cancer survival. Yet many people still struggle to get timely diagnosis, medicines, and supportive care. Gaps are widest for Aboriginal and Torres Strait Islander peoples, rural and remote communities, culturally and linguistically diverse groups, people with disability, temporary visa …

au (code pays fourni par la source)

Assessing inequalities in health utility scores among cancer patients undergoing systemic and radiation therapy

Rashidul Alam Mahumud, Padam Kanta Dahal, Md. Shahjalal

BACKGROUND: Cancer remains a leading cause of morbidity and mortality worldwide, with low- and middle-income countries like Bangladesh facing a dual burden of rising incidence and limited healthcare infrastructure. Socioeconomic disparities, particularly economic social class, may exacerbate the adverse effects of cancer …

au, bd (code pays fourni par la source)

Overall survival as a safety guardrail in cancer drug trials

Rashidul Alam Mahumud

Surrogate endpoints have accelerated access to oncology drugs but often leave uncertainty about net patient benefit. We propose a pragmatic framework that recentres overall survival (OS) as both the definitive patient-centred efficacy endpoint and a safety guardrail capable of detecting net harm …

au (code pays fourni par la source)